Product
PD-(L)1 antibody immunotherapy
1 clinical trial
1 indication
Clinical trial
Molecular Subtyping of Extensive Stage Small Cell Lung Cancer and Relevent Clinical SignificanceStatus: Recruiting, Estimated PCD: 2024-06-01
1 clinical trial
1 indication